Hartmann Taylor Wealth Management LLC Invests $295,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Hartmann Taylor Wealth Management LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 564 shares of the healthcare conglomerate’s stock, valued at approximately $295,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on UNH shares. UBS Group decreased their price objective on shares of UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating on the stock in a report on Wednesday. Argus cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a research report on Friday, June 20th. TD Securities restated a “hold” rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Barclays dropped their target price on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $415.57.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders bought 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $308.85 on Friday. The stock has a fifty day moving average of $336.21 and a 200-day moving average of $454.51. The stock has a market capitalization of $280.17 billion, a P/E ratio of 12.93, a price-to-earnings-growth ratio of 1.43 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business posted $6.91 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.